Greenwood Capital Associates LLC grew its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Get Rating) by 33.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,786 shares of the medical equipment provider’s stock after acquiring an additional 4,905 shares during […]
/PRNewswire/ BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products.
/PRNewswire/ BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies.
/PRNewswire/ BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products.